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Abstract
As part of the Immunological Genome Project (ImmGen), gene expression was determined in unstimulated (circulating)
mouse neutrophils and three populations of neutrophils activated in vivo, with comparison among these populations and
to other leukocytes. Activation conditions included serum-transfer arthritis (mediated by immune complexes),
thioglycollate-induced peritonitis, and uric acid-induced peritonitis. Neutrophils expressed fewer genes than any other
leukocyte population studied in ImmGen, and down-regulation of genes related to translation was particularly striking.
However, genes with expression relatively specific to neutrophils were also identified, particularly three genes of unknown
function: Stfa2l1, Mrgpr2a and Mrgpr2b. Comparison of genes up-regulated in activated neutrophils led to several novel
findings: increased expression of genes related to synthesis and use of glutathione and of genes related to uptake and
metabolism of modified lipoproteins, particularly in neutrophils elicited by thioglycollate; increased expression of genes for
transcription factors in the Nr4a family, only in neutrophils elicited by serum-transfer arthritis; and increased expression of
genes important in synthesis of prostaglandins and response to leukotrienes, particularly in neutrophils elicited by uric acid.
Up-regulation of genes related to apoptosis, response to microbial products, NFkB family members and their regulators, and
MHC class II expression was also seen, in agreement with previous studies. A regulatory model developed from the ImmGen
data was used to infer regulatory genes involved in the changes in gene expression during neutrophil activation. Among 64,
mostly novel, regulatory genes predicted to influence these changes in gene expression, Irf5 was shown to be important for
optimal secretion of IL-10, IP-10, MIP-1a, MIP-1b, and TNF-a by mouse neutrophils in vitro after stimulation through TLR9.
This data-set and its analysis using the ImmGen regulatory model provide a basis for additional hypothesis-based research
on the importance of changes in gene expression in neutrophils in different conditions.
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Introduction
The Immunological Genome Project (ImmGen) is a consortium
of immunologists and computational biologists who aim to
produce a comprehensive description of gene expression and a
model of its regulation in the immune system of the mouse [1–11].
In this context, we analyzed gene expression in neutrophils, in
order to determine gene expression patterns that distinguish
neutrophils from other leukocytes, compare expression patterns
among neutrophils activated by different stimuli in vivo, and infer
regulators of gene expression during neutrophil activation using
the ImmGen regulatory model.
Neutrophils are highly differentiated cells of the myeloid lineage
and are produced in large numbers in the bone marrow. They are
then released into the circulation, from which they extravasate in
response to a variety of inflammatory stimuli. Neutrophils are
specialized for defense against bacterial infection and are essential
for host survival in a normal environment. However, ‘‘acute’’
neutrophilic inflammation is also characteristic of diverse non-
infectious disease states such as inflammatory arthritis, neutro-
philic dermatoses, and vascultis.
Unstimulated neutrophils are short-lived, and many of the best-
known functions of activated neutrophils involve pre-formed
mediators. However, over the past 25 years it has become clear
that activated neutrophils have prolonged survival, that they
undergo prominent changes in gene expression, and that they
synthesize and secrete proteins [12–15], indicating that studies of
gene expression are biologically relevant. Gene expression
profiling of neutrophils has been reported in multiple studies,
mostly for human cells, sometimes ex vivo comparing disease
states [16–19] but more often in vitro after stimulation with
lipopolysaccharide, GM-CSF, or bacteria [19–24]. In all of these
studies, numerous changes in gene expression were seen with
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been up-regulation of anti-apoptotic genes [17,18,23,24] and
genes for pro-inflammatory cytokines and chemokines
[17,18,20,21,24]. Some authors have focused on other changes,
such as in genes for transcription factors [22] or related to antigen
presentation [19], and these papers have also reported differences
among different stimuli in vitro [19,22]. We are aware of only one
study of gene expression in mouse neutrophils, in which
neutrophils activated in vivo by thioglycollate-induced peritonitis
were found to express many genes previously thought to be specific
to macrophages [25]. Mouse neutrophils activated in vivo by
different stimuli have not been compared to each other, nor to
non-activated neutrophils.
The importance of particular regulators of gene expression has
been established most conclusively for the differentiation of
neutrophils; for example, PU.1, CEBP/a, CEBP/e, and Gfi-1
are essential for normal granulopoiesis [26–29]. During neutrophil
activation, studied using human cells in vitro, evidence for
involvement of STAT proteins, NFkB isoforms (specifically the
canonical pathway involving NFkB1/p50 and RelA), and CEBP/
a has been obtained [26,30].
In the current study, we obtained gene expression profiles from
unstimulated mouse neutrophils (bone marrow and blood) and
three disease states that involve extravasation and activation, in
order to identify genes that distinguish neutrophils from other
leukocytes, to identify changes in gene expression that are shared
among activated states, and to identify changes characteristic of a
particular stimulus. Uric acid (UA) crystals elicit inflammation in
the peritoneal cavity–a model for the human arthritic disease
gout–and initiate pro-inflammatory signals in leukocytes through
the NLRP3 inflammasome [31]. Thioglycollate broth (TG) elicits
neutrophilic and then macrophage inflammation in the peritoneal
cavity; this technique has been used for many years to study
neutrophils and especially macrophages, but no specific human
disease is modeled. The mechanism is undefined, but since yeast
extract is a component of the broth, signaling through multiple
innate-immune receptors is likely. Autoantibodies to glucose-6-
phosphate isomerase produce inflammatory arthritis with similar-
ities to the human disease rheumatoid arthritis. Neutrophils
infiltrate the synovial fluid (SF), through deposition of immune
complexes in the joint [32,33]. In all of these models, neutrophils
circulating in the blood are the precursors of the cells accumu-
lating in the inflamed sites and are an appropriate standard for
comparison. The fact that this project was part of ImmGen
allowed an additional and novel analysis: we used the ImmGen
regulatory model [10] to infer the importance of many transcrip-
tion factors in neutrophil activation.
Methods
Ethics Statement
All experiments using mice were conducted under protocols
approved by the HMA Standing Committee on Animals of
Harvard Medical School or the Institutional Animal Care and Use
Committee of the Boston University Medical Campus.
Mice
For experiments involving gene expression profiling, male
C57BL/6 mice were purchased from the Jackson Laboratory at
five weeks of age and maintained at Harvard Medical School for
one week before use in experiments.
For experiments using neutrophils in vitro, C57BL/6 wild-type
mice were purchased from the Jackson Laboratory. Irf52/2 mice
(backcrossed 8 generations to C57BL/6) were provided by Dr. T.
Taniguchi (University of Tokyo, Tokyo, Japan) and Dr. T. Mak
(University of Toronto, Toronto, Canada) [34] and then
backcrossed a further 7 generations to C57BL/6 mice from the
Jackson Laboratory. Mice were maintained at the Boston
University School of Medicine Laboratory Animal Sciences
Center and used under IACUC-approved protocol 14794.
Inflammatory Stimuli and Collection of Cells
Arthritis was induced using serum from K/BxN mice, 0.15 ml
intraperitoneally (i.p.) on day 0 and day 2. Synovial fluid was
collected on day 7 by puncture of the medial or lateral ankle with a
21-gauge needle, recovery of the fluid with a micropipet, and
immediate dilution in cold DMEM (without Phenol Red)
containing 5% FBS, 0.1% sodium azide (DMEM/FBS/azide),
and 20 mM EDTA. Peritonitis was induced by i.p. injection of
1 ml autoclaved 3% thioglycollate FTG medium (Sigma), or
0.1 ml of 10% uric acid (Sigma, non-crystalline) in 0.8% NaCl
that had been sonicated and stored at RT overnight to allow
crystals to form [35]. Peritoneal exudate cells were recovered
18 hr later by lavage with 9 ml cold DMEM/FBS/azide. Blood
was collected by cardiac puncture and immediately diluted into
cold DMEM/FBS/azide also containing 20 mM EDTA. Bone
marrow cells from femurs were extruded directly into cold
DMEM/FBS/azide.
Purification of Neutrophils, Flow Cytometry
In most cases, samples from two mice were pooled before
purification of neutrophils for gene expression studies. The
standard ImmGen protocol for staining and fluorescence activated
cell sorting (FACS) was used (www.immgen.org/Protocols/
ImmGen%20Cell%20prep%20and%20sorting%20SOP.pdf), in-
cluding a maximum of 2 hours between mouse sacrifice and
staining. RBC were removed by hypotonic lysis with ACK
medium for 3 min on ice for most samples. Removal of RBC from
blood samples required two treatments of 5–10 min each. The
remaining cells were stained with PE-conjugated anti-CD11b
(clone M1/70, eBioscience) and APC-Cy7-conjugated anti-Ly6G
(clone 1A8, BD Pharmingen) in DMEM/FBS/azide for 10 min,
and neutrophils were recovered by FACS (FACS Aria, Becton
Dickinson) based on high side-scatter, bright staining for Ly6G
and CD11b, and exclusion of doublets. Two cycles of FACS were
performed, and purity of the sorted cells was at least 99% after the
second sort. Fifty thousand cells were sorted directly into TRIzol
Reagent (Invitrogen) for recovery of RNA during the second sort.
Common myeloid precursors (CMP) were sorted as Lin
2IL7R-
Sca1
2cKit
+FcgR
luCD34
+ cells, and granulocyte/monocyte pre-
cursors (GMP) as Lin
2IL7R-Sca1
2cKit
+FcgR
hiCD34
+ cells. For
purification of other leukocyte populations, see www.immgen.org.
For purification of splenic leukocyte populations for gene
expression analysis by RNA-Seq, see www.immgen.org/
Protocols/11cells.pdf.
For purification of neutrophils for subsequent stimulation
in vitro, see below.
RNA Processing, Microarrays, and Data Processing
RNA purity was determined using an Agilent 2100 bioanalyzer,
and all samples had RNA Integrity (RIN) scores greater than 7 (on
a scale of 0–10), the standard for inclusion in ImmGen. Per
standard ImmGen protocol (www.immgen.org/Protocols/
Gene Expression Profiling of Mouse Neutrophils
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e108553Total%20RNA%20Extraction%20with%20Trizol.pdf), RNA was
amplified and hybridized to the Affymetrix MoGene 1.0 ST array
with the GeneChip Whole Transcript (WT) Sense Target Labeling
Assay per the manufacturer’s instructions. Raw data were
normalized using the GenePattern module ExpressionFileCreator
and its robust multichip average algorithm. Isolation of polyA+
RNA, RNA-Seq, and analysis of RNA-Seq data were performed
as described in www.immgen.com/Protocols/11cells.pdf.
Gene Expression Omnibus accession number: GSE15907.
Filtering of Genes to be Analyzed
For comparison of neutrophils to non-neutrophil leukocytes,
data from all probes on the array were used. Analyses comparing
neutrophil populations to each other or inferring regulatory genes
were limited to genes with mean expression .120 after
normalization in at least one neutrophil population, since this
level of expression on the 1.0 ST array has been associated with a
95% chance of protein expression and is being routinely used as
the cut-off value in ImmGen studies [36]. Significant variation
across neutrophil populations (ANOVA P,0.01), fold-difference
$2 in at least one pair-wise comparison of populations, and
acceptable variation within replicates (within-group coefficient of
variation (CV) ,0.5 across neutrophil populations) were also used
as filters for these analyses.
Analysis of Gene Ontology Categories and Functional
Pathways
The distribution of genes into Gene Ontology (GO) categories
and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways was analyzed using DAVID (http://david.abcc.ncifcrf.
gov/) and its default Benjamini-Hochberg adjustment for multiple
comparisons, with adjusted Q,0.05 regarded as significant. The
Functional Annotation Clustering tool in DAVID was used to
identify redundant GO categories and KEGG pathways.
Lists of genes analyzed using DAVID included genes over-
expressed or under-expressed in all neutrophil populations
compared to all non-neutrophil populations; genes up- or down-
regulated in SF, TG, or UA neutrophils relative to blood
neutrophils (2-fold or 1.5-fold); genes up- or down-regulated at
least 2-fold in SF, TG, or UA compared to all other neutrophil
populations; and genes implicated in a shared regulatory network
(see below). The numbers of genes in different GO categories or
KEGG pathways that were up- or down-regulated in these three
activating conditions were analyzed by Fisher’s exact test or chi-
square test in pairwise comparisons.
Categories and pathways of interest were studied in more detail.
Among genes down-regulated in neutrophils compared to non-
neutrophils, expression of all genes in the significantly enriched
GO categories (www.geneontology.org) was analyzed. For com-
parison of activated neutrophil populations, compilation of
significant GO terms and KEGG pathways was supplemented
by manual examination of gene lists and refinement of pathways
after consultation of the NCBI Gene annotations (ncbi.nlm.nih.
gov/gene) and the literature via PubMed. For analysis of
expression data for genes on the most of the resulting lists, filters
for expression (.120), significance (ANOVA Q,0.05 after
adjustment for multiple comparisons), and fold change (.2i na
pairwise comparison, in most cases) were retained, but the filter for
CV was removed due to the small numbers of genes being
analyzed simultaneously and incorporation of such variation into
analysis by ANOVA. For the list of genes in a pathway implicated
only after analysis of likely regulatory genes (see below), the fold-
change criterion was relaxed (.1.5) and the ANOVA criterion
removed, with genes not meeting the more strict criteria being
noted. Graphics were created using the Pathway Designer function
of Ingenuity Systems (www.ingenuity.com).
Visualization of Differences in Gene Expression
Global gene expression patterns in leukocyte populations were
compared by principal components analysis (PCA) using the
‘Population PCA’ tool (http://cbdm.hms.harvard.edu/
LabMembersPges/SD.html). Heat maps were produced using
GenePattern module HeatMapImage. For comparison of expres-
sion among neutrophil populations (blood, SF, UA, and TG),
expression was log-transformed and mean-centered across the 4
populations for each gene. The gradient was set to indicate an 8-
fold difference between lowest (dark blue) and highest (dark red)
expression, so as to allow visualization of 2-fold differences and
comparison among genes; for a few genes, the differences were
larger than 8-fold and are not fully appreciable.
Analysis Using the ImmGen Regulatory Model
Starting with the 1283 genes that had passed initial filters for
expression level and variation between and within groups as
above, expression data from individual replicates of neutrophils
purified from blood, SF, TG or UA were used to place genes into
clusters using ExpressCluster (http://cbdm.hms.harvard.edu/
LabMembersPges/SD/downloads/ExpressCluster_v1.3.pdf): K-
means clustering with k=32 clusters that converged after 13
iterations, using Euclidean distance as the distance metric with
mean-centered signal transformation. Correlation coefficients
were calculated for each cluster. Clusters showing similar patterns
but differing in magnitude were merged for subsequent analyses
(resulting in 25 clusters), and re-calculation of correlation
coefficients confirmed that such merging was appropriate, since
coefficients dropped little if at all (maximum drop 0.03). To assess
the statistical significance of the clustering process, normalized
expression values for all genes were randomized for each sample,
and that simulated data-set was analyzed by ExpressCluster and
correlation coefficients calculated in the same way.
In the ImmGen regulatory model, each gene is assigned to one
coarse (n=81) and one fine (n=334) module based on correlated
expression across all populations; each module is associated with
multiple regulators, with associations assigned weights based on
the beta-coefficients from a multiple regression equation unique to
each module [10]. Thus, each target gene in a dataset generates
multiple regulator-target pairs, and weights can be compared only
within modules, not between them. Some regulators are associated
with few modules, some with many, so the maximum number of
regulator-target pairs is highly variable among regulators. Since
there is no objectively ‘‘best’’ way to infer regulator importance
using this framework, we performed two analyses in parallel: i)
restricting the analysis to coarse modules with significantly
increased numbers of genes, then compiling the regulators of
those modules; and ii) for each regulator in light of its assignment
to coarse modules, comparing the number of regulator-target pairs
generated by a list of genes to the maximum number of regulator-
target pairs in the model.
Distribution of genes into the 81 coarse modules was compared
to a random distribution generated by simulation using custom
PERL script that measured total bin counts after 10,000 sets of
random distributions of X numbers into 81 bins with different sizes
determined by the number of target genes in each of the coarse
modules, where X is the number of unique genes in a particular
cluster group that was a target gene member of one of the coarse
modules. The 25 clusters were pooled into 3 groups (11 clusters of
up-regulated genes, 9 clusters of down-regulated genes, and 5 with
more complex patterns) in order to obtain acceptable statistical
Gene Expression Profiling of Mouse Neutrophils
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was regarded as significant. Regulators associated with these
modules were identified.
Analyses for enrichment of regulator-target pairs was also
performed using these 3 pools of clusters. Over-representation of
regulator-target pairs was determined by chi-square test with
adjustment for the false discovery rate, with Q,0.01 chosen as the
cut-off value in order to enrich for the most highly over-represented
regulators [37]. The list of regulators chosen for further analysis
included those that were over-represented in one of the 3 pools of
clusters and also had been associated with a significantly enriched
coarse module as above. The genes in each of the 25 individual
clusters were then analyzed similarly for enrichment of regulator-
target pairs, to create a matrix of P-values for each regulator with
each cluster of expressed genes. This matrix was subjected to
hierarchical clustering of both rows (regulators) and columns (clusters)
to identify related regulators and related gene clusters. The
HeatMapImage module in GenePattern was used for visualization.
Neutrophil Stimulation in vitro
Neutrophils were first enriched from bone marrow on a 62.5%
Percoll column [38], then stained with PE-conjugated anti-CD11b
(clone M1/70, eBioscience), PerCP-Cy5.5-conjugated anti-Gr1
(i.e., anti-Ly6G and/or Ly6C, clone RB6-8C5, BD Pharmingen),
and APC-conjugated anti-F4/80 (clone BM8, BioLegend). In one
experiment, cells were stained with PE-conjugated anti-CD11b
and FITC-conjugated anti-Ly6G (clone 1A8, BioLegend). Purified
neutrophils (CD11b
+Gr1
hiF4/80
2 or CD11b
+Ly6G
hi) were sorted
by FACS on a MoFlo instrument (Beckman Coulter). The
neutrophil population was .98% pure as assessed by Wright-
Giemsa stain of cytospun samples.
Neutrophils were resuspended in RPMI-1640 medium supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/
ml penicillin and 100 mg/ml streptomycin (complete medium) and
seeded at 3610
5 cells/well in 96-well round-bottom plates. They
were then incubated with the following TLR ligands for 16 hours:
the TLR2 ligand Pam3Cys-Ser-Lys4 (Pam3Cys) (100 ng/ml), the
TLR3 ligand poly(deoxyinosinic-deoxycytidylic acid) (poly(I:C))
(10 ug/ml), the TLR4 ligand LPS (100 ng/ml), and the TLR9
ligand CpG-B (oligodeoxynucleotide (ODN) 1826) (1 ug/ml) (all
from InvivoGen). Following incubation, the supernatants were
collected and concentrations of selected cytokines and chemokines
(IL-1b, IL-10, IP-10, KC, G-CSF, MIP-1a, MIP-1b, MIP-2, and
TNF-a) in the supernatants were measured by Luminex (National
Mouse Metabolic Phenotyping Center at the University of
Massachusetts Medical Center, using reagents from Millipore).
Results and Discussion
Neutrophils were purified by FACS, on the basis of forward-
scatter/side-scatter pattern and staining for Ly6G and CD11b [39],
from bone marrow, blood, and three inflammatory conditions: SF 7
days after induction of arthritis using autoantibodies, peritonitis 18
hours after injection of TG, and peritonitis 18 hours after injection
of UA (Fig. 1A). Cell purification was performed according to
ImmGen standard operating protocols, from 5-week-old C57BL/6J
male mice. Microarray gene expression profiles were generated on
triplicate samples using ImmGen standard pipelines for data
generation, processing, and quality control.
Gene expression in neutrophil populations with
comparison to other leukocytes
Based on analysis of global gene expression patterns by PCA,
the 5 neutrophil populations clustered distinctly from all other
leukocyte populations in ImmGen (Fig. 1B). This unique
expression pattern was driven both by over-expression and
under-expression of genes in neutrophils compared to the other
198 leukocyte populations: e.g., mean expression of 457 probes
was at least 4-fold higher in neutrophils than non-neutrophils, and
mean expression of 1179 probes was at least 4-fold lower. The
total number of probes with absolute expression .120 (used as a
cut-off because it is highly predictive of translation into detectable
protein) [36] was lower in neutrophils (range 9166–9437) than in
other leukocytes (mean 10198, range 9806–11342, P,0.0001
comparing neutrophils to any other type of leukocyte).
Genes with expression most specific to neutrophils were
identified in two ways: i) genes reliably expressed (absolute
expression .120) in all 5 neutrophil populations but in none of
the 198 non-neutrophil populations, and ii) minimum expression
among the 5 neutrophil populations at least 2-fold higher than the
maximum expression in any other leukocyte. Thirteen genes met
the first criterion, and 23 met the second, with 5 meeting both
criteria (Table 1). These 31 genes were not enriched in any Gene
Ontology (GO) term, and no functional theme was evident by
inspection. Data obtained from splenic leukocyte populations
using RNA-Seq, a different method to quantify mRNA, confirmed
neutrophil-specific expression of these genes (Table S1). Eosin-
ophils have not yet been profiled in ImmGen, but published data
using the same microarray platform [40] indicate that 10 of these
31 genes, including only 3 of the 13 genes expressed in all
neutrophil populations but no other leukocytes in ImmGen, are
definitely expressed in eosinophils (Table 1).
Two of the 31 genes (Csf3r and Cxcr2) are well-known to be
important in neutrophil biology and to be relatively but not
completely specific to neutrophils. Four other genes (Chi3l1,
Clec5a, Mgam, and Sgms2) have been studied in neutrophils but
also in other leukocytes [41–46]. The remaining 25 genes have not
been specifically studied in neutrophils; expression of 12 of them
has been reported to be relatively specific to neutrophils compared
to other leukocytes in an analysis of the BioGPS database [47], but
the other 13 did not appear in that signature (see Table 1).
Considering specificity beyond the hematopoietic system, 7 of
the 12 previously described and 11 of the 13 novel genes have
been reported to be expressed in at least one non-hematopoietic
cell type. Expression data were surveyed via the BioGPS website
(biogps.org) for the remaining 7 genes for which there was no
literature on expression, leading to the conclusion that Stfa2l1 and
Mrgpr2a and b (genes of unknown function) are particularly likely
to be specific to neutrophils. In our data-set, these genes were not
expressed in myeloid precursors, were highly expressed in mature
bone-marrow neutrophils, and continued to be expressed during
neutrophil circulation and activation. Stfa2l1 was not expressed
significantly in any non-neutrophil population, and the minimum
expression in neutrophils was 12-fold higher than the maximum
expression in non-neutrophil leukocytes (Table 1). In the
MOE430 Gene Atlas data-set (inspected on biogps.org), Stfa2l1
was expressed in mature granulocytes and bone marrow, but
otherwise only in umbilical cord at a low level. Mrgpra2a and b
were expressed at low levels in 3–4 non-neutrophil populations in
our data-set, with minimum neutrophil expression 3-fold higher
than maximum non-neutrophil expression; in the MOE430 data-
set, expression was high in mature granulocytes and bone marrow,
but otherwise only seen in the dorsal root ganglia.
Despite the unclear functional significance, these results are
consistent with the literature. As above, 16/31 genes (including
Stfa2l1 and Mrgpr2a and b) were among the 206 genes assigned
to neutrophil/granulocyte-oriented clusters in analyses of the
BioGPS dataset [47]. In turn, 155 of those 206 genes could be
Gene Expression Profiling of Mouse Neutrophils
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in neutrophils, particularly in unstimulated cells, but some
declined in activated cells and many were also expressed in other
leukocytes (File S1).
In contrast, genes encoding components of neutrophil granules
had two different patterns of expression, consistent with the
literature [48–50]: expression of primary (azurophilic) granule
components was virtually limited to granulopoiesis (granulocyte-
monocyte precursor, GMP), and expression of components of
secondary (specific), tertiary, or secretory granules peaked at the
mature stage in the bone marrow and declined among circulating
and activated cells (Fig. 1C). In agreement with these findings,
published analyses of BioGPS and other databases have also
incorporated a few genes for secondary/tertiary granule proteins
(Fpr1, Lcn2, Ltf, Orm1, Mmp8), but no genes for primary granule
proteins, into granulocyte signatures [47,51]. Thus, the canonical
proteins of neutrophils do not serve as an ideal genetic signature
for mature neutrophils, which has implications regarding strategies
for identifying evidence of neutrophil infiltration or contamination
in studies of complex tissues. The highly neutrophil-specific genes
we have identified, such as Stfa2l1 and Mrgpra2a and b, are good
candidates for development of Cre-expressing mice with greater
specificity for neutrophils than the best currently-available model
based on human MRP8 [52] (equivalent to mouse S100a8, which
showed good specificity in our studies as well but did not meet our
strict criteria, see immgen.org). The genes of unknown function in
Table 1 are also good candidates for study related to unique
neutrophil actions such as NETosis.
The genes most specifically under-expressed in neutrophils were
identified in an analogous way as with over-expressed genes. Sixty-
five probes had minimum expression in non-neutrophils more
than 2-fold greater than maximum expression in neutrophils, 98
probes were expressed in all 198 non-neutrophil populations but in
none of the 5 neutrophil populations, and 17 probes met both
criteria, leaving 146 probes associated with 120 genes. These genes
were significantly enriched in GO categories related to translation,
e.g., rRNA metabolic process, rNMP biosynthesis, tRNA
aminoacylation, nucleocytoplasmic transport (all Q,0.05 after
Benjamini-Hochberg adjustment), and related/redundant catego-
ries. Almost all of the remaining genes (i.e., those that did not meet
the strict criteria for being specifically under-expressed) in the first
3 of these categories were also expressed at lower levels in
neutrophils than non-neutrophils (Fig. 1D). These results are
consistent with the previously-described scarcity of ribosomes in
neutrophils [53] and probably reflect a conservation of energy for
other processes during a short lifespan. Although limited
availability of ribosomes and/or tRNAs is probably the reason
that gene expression in neutrophils does not always correlate with
protein production [12,20], it remains unclear whether there is a
mechanism for prioritization for translation above and beyond
merely the relative abundance of different mRNAs [12].
Comparison of neutrophils activated by different stimuli
As described in more detail in Text S1 and Figure S1, changes
in gene expression in SF, TG, and UA neutrophils were compared
using plots comparing fold-changes relative to blood neutrophils,
Venn diagrams, and statistical analysis of distribution into GO
categories. To summarize, the majority of differences were
quantitative rather than qualitative. In particular, correlation
was high (r=0.79) between TG and UA, but changes in TG were
of greater magnitude. The lowest correlation was between SF and
UA (r=0.55), and very few changes in gene expression were seen
in both SF and UA but not TG. Down-regulation of individual
genes was more likely to be shared among all 3 conditions than
was up-regulation.
Because these analyses had low power to detect changes in small
numbers of related genes, we also identified every gene with
expression in TG, SF, or UA that was at least 2-fold higher than in
either of the other conditions and in blood. Seventy-nine genes
were relatively specific for TG, 49 for SF, and 13 for UA (Table
S2). Inspection of these lists revealed several groups of genes with
shared functions. TG neutrophils up-regulated NFkB subunits and
regulators, enzymes involved in gluthathione metabolism and
other antioxidants, and signaling molecules in pathways for
responding to microbial products. SF neutrophils up-regulated
MHC class II genes, the C1q component of complement, all 3
members of the Nr4a nuclear hormone receptor subgroup (Nr4a1,
2, and 3), and molecules related to the uptake and metabolism of
lipoproteins. UA neutrophils up-regulated two receptors for
leukotrienes (Cysltr1 and Ltb4r1). Genes specifically down-
regulated in TG (n=3), SF (n=42), or UA (n=9) did not contain
any shared functions that were obvious on inspection, nor by
analysis using DAVID.
We proceeded to analyze and interpret the functions of genes
up-regulated or down-regulated in activated neutrophils, whether
shared among activating conditions or relatively specific to one
condition.
Functions of genes up-regulated in activated neutrophils
Most of the GO biological processes in which genes up-
regulated in activated neutrophils were enriched were very broad
and not surprising: apoptosis, regulation of apoptosis, immune
system development, cellular ion homeostasis, inflammatory
response, regulation of leukocyte activation, regulation of cytokine
production, response to oxidative stress, positive regulation of
catalytic activity, phosphorus metabolic process, regulation of
small GTPase mediated signal transduction, protein homooligo-
Figure 1. Isolation of neutrophils and characterization of gene expression patterns. A. Neutrophils were isolated from bone marrow (BM)
and blood (BL) of untreated mice, from the peritoneal cavity of mice administered thioglycollate (TG) or uric acid (UA) intraperitoneally, and from the
synovial fluid (SF) of mice with autoantibody-induced arthritis, on the basis of scatter patterns (which differed among conditions, left panels) and
staining for CD11b and Ly6G (right panels). The population in the upper left corner of the TG plot did not express CD11b or Ly6G. B. Comparison of
global gene expression patterns in neutrophils (labeled) to all of the other populations in ImmGen, using axes determined by principal components
analysis (PCA). Populations in red on the right side of the diagram represent stromal cell populations; other colors represent various lymphoid and
myeloid populations. To convert ImmGen nomenclature to the abbreviations used in this paper: Thio.PC=TG; UrAc.PC=UA; Arth.SynF=SF;
GN.Bl=BL; GN.BM=BM=bone-marrow neutrophils from normal mice; Arth.BM=bone-marrow neutrophils from arthritic mice, note similarity to
GN.BM. C. Expression of genes for components of neutrophil primary granules (top), secondary granules (middle), and 15 genes showing greater
expression in neutrophils than non-neutrophils in ImmGen [mean expression among 5 neutrophil populations (BM, BL, SF, UA, and TG) being greater
than 4 times the maximum expression among 198 non-neutrophil populations](bottom), during neutrophil development and activation.
CMP=common myeloid precursor; GMP=granulocyte/monocyte precursor. Note that expression patterns in the ‘‘neutrophil-specific’’ genes as
identified in this study resembled those of secondary but not primary granule components. D. Expression of groups of genes related to translation
(per Gene Ontology=GO) in neutrophils (blue) and other leukocytes (red). Each bar represents mean expression among 5 neutrophil or 198 non-
neutrophil populations, and error bars show standard errors.
doi:10.1371/journal.pone.0108553.g001
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focused further analysis on the 10 significant GO terms with 50 or
fewer genes. These more-specific terms still often shared genes,
which allowed functions of interest to be summarized as: i)
regulation of apoptosis, ii) pro-inflammatory signaling through
NFkB including pathways for responding to microbial products,
iii) glutathione metabolism, and iv) antigen processing and
presentation. Analysis for enrichment in KEGG pathways
corroborated the first 3 of these functions and also indicated that
genes for lysosome components, not surprisingly, were significantly
up-regulated in all three activated populations. Inspection of genes
specifically up-regulated in one activating condition (Table S2)
had also indicated that the latter 3 of these functions were of
interest, as were metabolism of lipoproteins, Nr4a-family nuclear
receptors, and receptors for leukotrienes.
Uptake and metabolism of modified lipoprotein. Up-
regulation of multiple endocytic receptors for VLDL (Lrp1) and
oxidized LDL (Cxcl16, Olr1, Cd36) was most prominent in SF
neutrophils, whereas induction of lysosomal lipase (Lipa) and
signaling receptors for lysophosphatidylcholine (Gpr132) and free
fatty acids (Gpr84) was most characteristic of TG neutrophils
(Fig. 2A). Uptake of modified lipoproteins, breakdown of
triglycerides and cholesterol esters, and export of cholesterol are
all well-described in macrophages, and dysfunction of this system
is important in foam cell formation in atherosclerosis [54,55].
Similar mechanisms are not known to operate in neutrophils. No
previous studies have commented on up-regulation of genes
related to lipoprotein metabolism, but corroboration of this finding
at the level of gene expression is provided by review of data from
human neutrophils stimulated in vitro: transcripts for CD36,
CXCL16, GPR132, LRP1, OLR1, and additionally MSR1 were
up-regulated by LPS and/or GM-CSF [19].
Nr4a family members. Nr4a1 (Nur77), Nr4a2 (Nurr1), and
Nr4a3 (NOR-1) are ligand-independent transcription factors in
the nuclear hormone receptor superfamily whose expression is
induced rapidly in a variety of cell types following a wide range of
inflammatory or non-inflammatory stimuli [56,57]. Expression of
Nr4a family members is induced by inflammatory cytokines or
oxidized lipids in murine macrophages [58], and by live bacteria
or to a lesser extent LPS in murine mast cells [59]. Expression in
neutrophils at the protein level has not been described, but all
three NR4A family members were among the many transcription
factors noted to have significant changes in gene expression in one
study of human neutrophils, and these changes differed among the
three stimuli used in vitro [22]. In another study, NR4A3 was
induced by either LPS or GM-CSF/IFNc in vitro [19]. In our
experiments, Nr4a2 and Nr4a3 were up-regulated only in SF
neutrophils, and Nr4a1 was up-regulated more in SF than TG
neutrophils (Fig. 2B). These 3 genes were among the 49 genes
with at least 2-fold higher expression in SF than in blood, TG, or
UA neutrophils. Nr4a proteins have been shown to both induce
and suppress expression of inflammatory genes [56]. Nr4a proteins
play important roles in stimulating lipolysis and utilization of
glucose [56], which is intriguing in light of the up-regulation of
genes related to uptake and metabolism of lipids particularly in SF
neutrophils.
Glutathione metabolism. Also notable was differential
regulation of genes related to the synthesis, use, and recycling of
glutathione, particularly in TG neutrophils (Fig. 2C). Increased
capacity to synthesize glutathione is suggested by up-regulation of
the genes for the rate-limiting enzyme, glutamate-cysteine ligase
(Gclc, Gclm), extracellular enzymes that cleave plasma glutathione
to provide a source of cyst(e)ine for cellular use (Ggt1, Ggt5), and
the major transporter for cyst(e)ine (Slc7a11) [60]. In contrast,
expression of several genes related to the oxidation-reduction cycle
of glutathione and NADP (G6pd2, G6pdx, Gpx1, Idh1) was down-
regulated in SF neutrophils. Glutathione is known to be important
in multiple facets of neutrophil biology, e.g., production of
cysteinyl-leukotrienes [61] and a range of activities dependent on
microtubule assembly, such as chemotaxis, degranulation, and
phagocytosis [62], but the details of regulation of glutathione
synthesis and use have not been studied intensively in neutrophils.
Interpretation of our data as a response to oxygen stress is
supported by the finding that expression of genes for five other
anti-oxidant enzymes (Cat, Prdx1, Prdx6, Sod2, and Txnrd1) was
also increased specifically in TG neutrophils (Fig. 2C).
Arachidonic acid metabolites. Changes in genes related to
arachidonic acid metabolites suggested increased synthesis of
prostaglandins (upregulation of Ptgs1/Cox1 and Ptgs2/Cox2) and
decreased synthesis of leukotrienes (upregulation of Dpep2 and
Ptgr1, downregulation of Mgst2, Ggt5, and Lta4h). Particularly
notable was upregulation of Ptgs1/Cox1 and two leukotriene
receptors (Cysltr1 and Ltb4r1) specifically by UA (Fig. 2D), an
expression pattern that was uncommon in the dataset overall.
Neutrophils are known to produce both leukotrienes and
prostaglandins in response to uric acid [63,64], immune complexes
[65], or microbes [66,67]. Our data suggest that this pathway may
be upregulated more by UA in the peritoneal cavity than by TG in
the peritoneal cavity or by immune complexes in SF. In that
setting, it is intriguing to note that in humans, gout (caused by UA
crystals) appears to respond better to inhibitors of cyclooxygenases
(the products of the COX/PTGS genes) than do other forms of
inflammatory arthritis, but with the caveat that in mice, COX-1
inhibitors are effective in preventing arthritis using the same model
used in this study [68].
Antigen processing and presentation. Genes for MHC
class II molecules (H2-Aa, H2-Ab1, H2-Eb1) were significantly
up-regulated only in SF neutrophils, and invariant chain (Cd74)
was up-regulated in SF and TG neutrophils (Fig. 2E). Among co-
stimulatory molecules, expression of Cd80 appeared to be up-
regulated in all 3 activated neutrophil populations. Genes for
several proteases involved in production of peptide antigens (Ctsb,
Ctsl, Ctss, Lgmn) and for a reducing agent important in antigen
processing (Ifi30/Gilt) were also up-regulated particularly in SF
neutrophils (Fig. 2E). Induction of genes related to antigen
presentation has been noted to differ with different forms of
activation of human neutrophils in vitro [19]. Mouse neutrophils
co-incubated with T cells in vitro express MHC class II, CD80,
and CD86 proteins and can process and present exogenous
antigen to T cells [69]. In the same study, freshly isolated TG
neutrophils did not express MHC class II proteins, consistent with
our gene expression data. Thus, the conditions in SF may promote
antigen presentation by neutrophils more effectively than perito-
nitis induced by TG or UA, but this hypothesis requires
confirmation at the level of protein expression.
Apoptosis. Regulation of apoptosis in neutrophils has been a
subject of intensive study. Apoptosis is the normal, non-inflam-
matory mechanism by which unstimulated neutrophils die after a
short time in the circulation, and inhibition of apoptotic cell death
is one of the salient features of neutrophil activation [14,15,70,71].
Because of this literature, and because induction of anti-apoptotic
genes has been commented upon in multiple previous studies of
gene expression in activated neutrophils [17,18,23,24], and
because interpretation of gene expression patterns alone provides
little insight into the activity of apoptotic pathways, we will only
comment briefly on our data. Expression of several pro-apoptotic
receptors (Fas, Tnfrsf1b), Bcl-2 family members (Bcl2l11=Bim;
Bax), and caspases (Casp8) was up-regulated, particularly in TG
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apoptotic Bcl-2 family members (Bcl2l1=Bcl-XL; Bcl2a1-
4=A1) and other inhibitors (Cflar, Xiap), again predominantly
in TG neutrophils (Fig. 2F). Consistent with the literature, among
anti-apoptotic genes, Bcl2 was not expressed, but Mcl1, known to
be important in protection of neutrophils from apoptosis [70,71],
was expressed in all neutrophil populations at higher levels than in
most other leukocytes (mean 6405+/2826, versus 2649+/21182).
Finally, the up-regulation of the glutathione pathway and anti-
oxidant enzymes (see above) particularly in TG neutrophils can be
interpreted as an anti-apoptotic response [72].
NFkB and its proximal regulators. Genes encoding the
non-canonical NFkB subunits (Nfkb2 and Relb) were up-
regulated, as were genes encoding inhibitors of NFkB( Nfkbia, d,
and e) and a kinase that inactivates these inhibitors in the non-
canonical pathway (Ikbke, along with the regulatory subunit Ikbkg/
Nemo), particularly in cells elicited with TG (Fig. 2G). These
results suggest up-regulation of the non-canonical NFkB pathway.
Members of the canonical NFkB pathway are present in resting
human neutrophils, and activation of this pathway in neutrophils
activated by various stimuli has been described [30]. In the same
study, the non-canonical isoforms NFkB2/p52 and RelB were not
detected in resting cells, but it was not reported whether these
isoforms were searched for after activation [30]. Thus, it is not
clear that NFkB2/RelB involvement in activated neutrophils has
been ruled out even in the specific setting of human cells
stimulated in vitro, and increased expression of mRNA for one or
both of these isoforms in stimulated human neutrophils has been
found in multiple other studies [19–22]. Since much of the
regulation of NFkB activity is post-transcriptional, it is difficult to
draw conclusions on the basis of transcription patterns, other than
to say that use of the non-canonical pathway is plausible. For
example, McDonald et al. reported increased transcription of IkB-
a (Nfkbia) after neutrophil activation, as has been seen in multiple
other studies including this one [19,20,22], but noted that this
increase occurred in response to the degradation of IkB-a protein
[30]. Therefore, the change seen in mRNA for Nfkbia is
biologically relevant, but interpretation is not straightforward in
a system subject to feedback regulation.
Pathways forresponding to microbialproducts. Signaling
pathways from pattern recognition receptors (PRRs) for microbial
products, including multiple Toll-like receptors (TLRs), NOD-like
receptors (NLRs), and inflammasomes, are known to operate in
neutrophils [73–75]. These pathways are also presumed or known
to be relevant to the three inflammatory conditions being studied:
autoantibody-induced arthritis is exacerbated by the TLR4 agonist
lipopolysaccharide (LPS) [76], uric acid crystals deliver inflamma-
tory signals via the NLRP-containing inflammasome [31], and
although the pro-inflammatory components of thioglycollate broth
have not been identified, the fact that it is a microbial extract makes
it highly likely that multiple microbial products are involved.
Components of the NLR and inflammasome pathways were
most prominently altered in TG neutrophils (Fig. 2H). Since both
stimulatory (Nod1, Birc3, Pycard/Asc, Hsp90) and inhibitory
(Tnfaip3/A20, Mefv/Pyrin) components were up-regulated, as
were both pro-inflammatory (NFkB pathway, as above) and pro-
apoptotic (Casp8) downstream effectors, the net biologic effects of
these changes are difficult to predict. In contrast, multiple
members of a pathway for sensing cytoplasmic DNA (Zbp1/Dai,
Tmem173/Mita, Ripk3/Rip3) were equally up-regulated in TG
and UA but not SF neutrophils. Changes in components of TLR
pathways were more complex, but up-regulation of Tlr4 and
Cd14 in multiple conditions, up-regulation of two components of
the MyD88-independent pathway downstream of Tlr4 (Traf3,
Tbk1) specifically in TG neutrophils, and down-regulation of the
MyD88-dependent pathway component Irak4 as well as a secreted
LPS-binding protein (Lbp) specifically in SF neutrophils suggested
that response to LPS is a particular object of differential regulation
under different stimulating conditions (Fig. 2H).
Signaling from Tlr4 and other TLRs proceeds not only to
NFkB and apoptotic pathways, but also to multiple interferon-
inducible regulatory factors (IRFs), which we will discuss in more
detail later since their importance was implicated by a separate
analysis.
Functions of genes down-regulated in activated
neutrophils
Although down-regulated genes were nearly as numerous as up-
regulated genes (see Fig. S1), they were not distributed as clearly
into functional groups. Only 3 GO terms, redundant and
consisting of multiple genes for histones, showed significant
enrichment in any activating condition. Further analysis of histone
genes revealed down-regulation of most genes in the replication-
dependent histone clusters [77], most strikingly the genes for H3
isoforms, in all 3 activated populations. However, expression of
replication-independent histone genes, particularly the ‘‘replace-
ment variant’’ H3.3 genes H3f3a and H3f3b, was unchanged
(Fig. 2I). Most likely, this finding simply reflects the fact that
neutrophils do not divide, but it is also possible that neutrophils
produce a unique complement of histones related to the
production of neutrophil extracellular traps (NETs) [78], the
anti-microbial properties of histones [79], or the toxic or
regulatory interactions of extracellular histones with other cells
[80,81].
Figure 2. Biological processes showing up-regulation or down-regulation of genes in activated neutrophils. (A–H). Heat maps show
mean expression in neutrophils from blood (BL), synovial fluid (SF), or peritonitis induced by uric acid (UA) or thioglycollate (TG). Mean expression
across all four conditions was placed at the center of the gradient (white) for each gene. Red indicates increased expression, and blue indicates
decreased expression. The full color gradient for each gene represents an 8-fold difference in expression. Lists of genes of interest were compiled
using the KEGG and Ingenuity databases as well as literature reviews; only genes showing at least 2-fold differences in expression comparing
conditions and with Q,0.05 by ANOVA are shown. In the pathway diagrams, up-regulated genes are shown in red, and down-regulated genes are
shown in green. A. Uptake and metabolism of lipoproteins. B. Nr4a-family transcription factors. C. Glutathione metabolism. D. Synthesis of and
response to leukotrienes and prostaglandins. E. Antigen processing and presentation via MHC class II. F. Genes related to apoptosis. G. NFkB
subunits and proximal regulators of NFkB. H. Genes related to signaling by innate immune receptors for microbial products. I. Expression of H3
histone genes (Hist1h3a, b, c, d, e, g, h, I, and Hist2h3b and 3c1) in neutrophil populations. Mean 6 SD of these 10 genes (black) declined after release
from bone marrow (BM) to blood (BL) and further after activation (SF, UA, TG). Mean 6 SD among 198 non-neutrophil populations is shown for
comparison. Although it is not apparent from this plot, the lowest expression among non-neutrophils exceeded the highest expression in UA or TG
neutrophils. Expression of genes for the ‘‘replacement’’ H3 histones, shown in red and blue, was maintained after neutrophil maturation and
activation, at levels similar to non-neutrophils.
doi:10.1371/journal.pone.0108553.g002
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in neutrophil activation
One of the major products of ImmGen is the definition of
modules of genes whose expression is correlated across leukocyte
populations, with subsequent assignment of probable regulatory
genes to each module [10]. In order to use this regulatory model to
predict which regulators are important in neutrophil activation
under different conditions, we first separated genes into 25 clusters
of 1–128 genes, defined by similar patterns of expression, using K-
means clustering of expression data from the individual replicates
of SF, TG, UA, and blood neutrophils (File S2). The validity of
this approach was supported by the fact that correlation
coefficients (comparing individual genes to the mean expression
profile for each cluster) were 0.86–0.94, whereas coefficients
generated using randomized expression data did not exceed 0.75
(data not shown).
To identify regulators of interest, genes within pools of clusters
(11 clusters of genes up-regulated versus blood, 9 clusters of down-
regulated genes, and 5 clusters of genes both up- and down-
regulated in different populations, to improve statistical power)
were analyzed for distribution into ImmGen modules and for
over-represented association with particular regulatory genes via
those modules (see Methods). Importantly, these modules and
assignment of regulatory genes were defined before any data from
activated neutrophil populations were included in the ImmGen
database (thus avoiding any bias), and the module definitions did
not change after incorporation of these data.
Sixty-four regulators were implicated using this approach. The
degree of over-representation of regulated genes in each of the 25
individual gene clusters was then determined (P-value of chi-
square test), and these data were used to create a matrix of P-
values for each regulator with each cluster. Hierarchical clustering
of this matrix was informative (Fig. 3A). Clusters of up- and
down-regulated genes clustered independently of each other, with
the 5 clusters of more complex patterns mixed in. Among clusters
of up-regulated genes, there was some clustering of patterns
characterized by particularly high expression in TG neutrophils,
or SF neutrophils, or both TG and UA but not SF neutrophils.
These results confirmed that implicated regulators were shared
across related expression patterns. Twenty-two regulators were
prominently associated with multiple clusters of up-regulated
genes and few if any other patterns; conversely, 5 regulators were
strongly associated primarily with down-regulated genes. Twenty
regulators were associated with many clusters with a variety of
patterns and thus were implicated in both up- and down-
regulation of genes. All of these 47 regulators appeared to be
associated with changes in gene expression across all 3 activating
conditions.
In contrast, the remaining 17 regulators were associated with
combinations of clusters that shared patterns specific to activating
conditions. Seven regulators were associated mostly with down-
regulated genes, but particularly for genes down-regulated in SF.
Ten regulators were associated with 5 clusters in which gene
expression was up-regulated in TG and UA, but not SF. Four of
these 5 clusters showed convincing association with the 10
regulators and were examined to see whether additional functional
pathways could be identified.
Interferon regulatory factors (IRFs) in activated
neutrophils
The list of 203 genes that were up-regulated in TG and UA but
not SF and that were implicated in a shared regulatory network
was analyzed using DAVID. After adjustment for multiple
comparisons, no GO category showed significant enrichment.
The chemokine signaling pathway in KEGG was significantly
enriched (Q=0.03), but the 9 genes in this pathway included
several that are involved in many pathways (e.g., Akt3, Nfkb1,
Stat2), so this result was not particularly informative. In contrast,
inspection of the list showed multiple genes for oligoadenylate
synthases (Oas1a, Oas1g, Oas2, and Oasl2), and genes regulating
expression of Oas or co-regulated with Oas were found to have
similar patterns of expression (Fig. 3B). This result supports the
hypothesis that Irf9, probably induced via the type I interferon
receptor, plays a role in up-regulation of genes in TG and UA but
not SF neutrophils. Irf9 has not been implicated in neutrophil
function previously.
Two other IRFs were among the 64 regulators implicated in
neutrophil activation. Irf7 was in the same group of 10 regulators
as was Irf9, associated with up-regulation of genes by TG and UA
but not SF (see Fig. 3A). Several genes that we had identified as
being up-regulated in the TLR signaling and cytosolic DNA-
sensing pathways (see Fig. 2H) encode members of pathways that
activate Irf7 or induce Irf7, adding to the plausibility that Irf7
plays a role in neutrophils activated via the pathways of innate
immunity. Irf7 was expressed at similar levels in both unstimu-
lated and activated neutrophils, but Irf7 activity is also regulated
by post-translational modifications, including phosphorylation (see
Fig. 2H) [82].
Irf5, in contrast, was implicated in both up- and down-
regulation of genes in all 3 activating conditions (see Fig. 3A).
Expression of Irf5 mRNA was easily detectable in blood
neutrophils (mean 495) and increased significantly in SF (mean
909, P,0.0001), UA (mean 1204, P=0.03), and TG (mean 1727,
P,0.0001) neutrophils. Irf5 has diverse functions that include the
induction of type I interferons and proinflammatory cytokines
following viral infection or downstream of Toll-like receptors
(TLRs) and nucleotide-binding oligomerization domain 2 (NOD2)
[34,83–87], and participation in apoptotic pathways induced by
viral infection, DNA damage, Fas-ligand, or tumor necrosis factor-
related apoptosis inducing ligand (TRAIL) [86,88,89]. However,
Irf5 has not previously been implicated in neutrophil biology. To
determine whether Irf5 plays a role in neutrophil function, we
isolated bone marrow neutrophils from IRF5-deficient (Irf52/2)
and wild-type (WT) mice and compared their secretion of
cytokines and chemokines in vitro in response to ligands for
different TLRs. Fifteen candidate cytokines/chemokines were
originally chosen on the basis of gene expression .75 in a
neutrophil population in ImmGen, inclusion in an Irf5-regulated
ImmGen module, inclusion in a cluster predicted to be regulated
by Irf5 in the current experiments, and/or known production by
human neutrophils in vitro [13]; secretion of IL-1a, IL-12(p40),
IL-15, MCP-1, M-CSF, and MIG was not detectable in our model
system in a preliminary experiment, so only 9 mediators were
studied further.
Irf52/2 neutrophils (CD11b
+Gr1
hiF4/80
2) secreted less IL-
10, IP-10, MIP-1a, MIP-1b, and TNF-a than WT neutrophils in
response to a TLR9 agonist (Fig. 3C). Analogous results with
lower absolute amounts were obtained in a single experiment
using FACS-sorted Ly6G
hiCD11b
+ neutrophils (data not shown).
In contrast, Irf52/2 and WT neutrophils secreted comparable
amounts of these proteins in response to TLR2 or TLR4 agonists,
demonstrating that the difference in TLR9-induced responses
between WT and Irf52/2 neutrophils was not due to a
generalized inability of the Irf52/2 neutrophils to respond
(Fig. 3C). Conversely, G-CSF was detectable after treatment with
the TLR9 agonist in this model system and did not differ between
Irf52/2 and WT neutrophils (data not shown), indicating that the
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PLOS ONE | www.plosone.org 11 October 2014 | Volume 9 | Issue 10 | e108553Figure 3. Regulatory genes implicated in neutrophil activation, with further focus on IRF family members. A. Genes were placed into
25 clusters (1–128 genes each, shown as the column headings; A and B are used to identify clusters that have the same numbers of genes) based on
patterns of expression in individual samples of neutrophils from blood, SF, UA, and TG, as shown in the heatmap at the top. Clusters that clearly
represented up-regulated (U) or down-regulated (D) genes (relative to blood) were pooled and were used to generate a list of predicted regulatory
genes (rows) showing enrichment based on the ImmGen regulatory model. Association of each of the 64 regulators with each of the 25 gene clusters
was then quantified (P-value of chi-square test), and this matrix of P-values was subjected to hierarchical clustering in order to identify related
regulators (rows) and related gene clusters (columns). The lower heatmap indicates these P-values (darker=lower), and the dendrogram and colored
bars on the right show groups of regulators with similar patterns of association with various gene clusters. The presence of patterns in the top
heatmap (e.g., clustering of clusters characterized by up-regulation in TG, SF, or UA, or by down-regulation in SF), which shows normalized average
expression in the 4 neutrophil populations in each cluster, validates this method. The group of regulators shown in light blue was associated with
gene clusters indicated in bold; inspection of genes in these clusters led to implication of the type 1 interferon pathway and Irf9. B. Up-regulation of
genes induced by type 1 interferons via Irf9, in TG and/or UA but not SF neutrophils. The heatmap shows mean expression in blood (BL), SF, UA, and
TG neutrophils. Mean expression across all four conditions was placed at the center of the gradient (white) for each gene. The full color gradient for
each gene represents an 8-fold difference in expression. The list of genes of interest and the pathway diagram were generated using the KEGG and
Ingenuity databases. Only genes showing at least 1.5-fold differences in expression comparing conditions are shown in the heatmap. In the pathway
diagram, genes showing statistically significant (Q,0.05 by ANOVA) differences that varied 2-fold in at least one pairwise comparison of conditions
are shown in red, and genes showing fold differences of 1.5–2 and/or not meeting statistical significance are shown in pink. C. Irf5 is required for
production of several cytokines and chemokines by mouse neutrophils stimulated in vitro with the TLR9 ligand CpG-B, but not for production
induced by the TLR2 ligand Pam3Cys nor the TLR4 ligand LPS. The panels show the mean 6 SEM of 3 independent experiments using FACS-sorted
Gr1
hiCD11b
+F4/80
2 neutrophils. Since secretion varied between experiments but reliably did so in parallel for the different analytes, data were
analyzed by determining the fold difference between Irf52/2 and WT in each experiment and applying one-sample T-tests to the fold-differences for
the 3 experiments. P values for cells treated with CpG were 0.014 for TNF and ,0.01 for the other proteins, and 0.13–0.97 for other TLR ligands.
doi:10.1371/journal.pone.0108553.g003
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indicate non-specific toxicity. No differences were seen in secretion
of IL-1b, KC, or MIP-2 between Irf52/2 and WT neutrophils
with any TLR agonist (data not shown, P values 0.076–0.66).
Although our primary aim was simply to see whether secretion
of cytokines/chemokines by neutrophils stimulated through any
TLR was Irf5-dependent, and thereby to provide functional
validation of the importance of Irf5 as a novel regulator of
neutrophil function implicated via the ImmGen regulatory model,
discussion of the relevant literature is warranted. Dependence of
TLR-induced inflammatory cytokine production upon Irf5 has
varied widely with the cell types studied [34,87,90,91], but there is
definitely precedent for TLR9-induced secretion of TNF being
reduced in mouse macrophages or dendritic cells lacking Irf5
[34,91]. Transfection of IRF5 into a human B lymphoma cell line
increased production of MIP-1a, MIP-1b, IP-10, and other
chemokines after stimulation by viruses in vitro [83].
Seemingly in contrast to our data, forced expression of IRF5 in
human macrophages decreased production of IL-10, and bone-
marrow-derived macrophages from Irf52/2 mice secreted more
IL-10 than did cells from wild type mice [92], but the cell types
and model systems differed from those used in our experiments.
Finally, Zhang et al. called into question many earlier reports of
cytokine secretion by neutrophils by using data from neutrophils
purified using antibodies to Ly6G rather than Gr-1 (which binds
both Ly6C and Ly6G) [39]. We used negative selection of cells
staining for F4/80 and bright staining for Gr-1, rather than simply
positive staining for Gr-1, and therefore undoubtedly achieved
better purification than in some early papers. However, the results
we obtained in a single experiment using Ly6G sorted cells are also
quite similar to those obtained by Zhang et al.; we agree that the
absolute amounts of TNF are small on a per-cell basis, but our
goal was to determine whether such secretion was Irf5-dependent
rather than to compare it to the much larger amount made by
macrophages.
Summary and Conclusions
Neutrophils exhibit a pattern of gene expression distinct from
that of other mouse leukocytes, with that distinction determined at
least as much by genes that neutrophils down-regulate (e.g., genes
related to translation) as by genes that they up-regulate.
Nevertheless, a moderate number of genes were relatively
neutrophil-specific and continued to be expressed after neutrophil
activation, and most of these genes, such as Stfa2l1 and Mrgpr2a
and b, are of unknown function. The major caveat to this
interpretation is that gene expression patterns in eosinophils have
not yet been reported in ImmGen or any other comprehensive
database.
Numerous changes in gene expression were seen after
neutrophil activation in vivo, particularly in peritoneal neutrophils
elicited with TG compared to peritoneal neutrophils elicited with
UA or SF neutrophils elicited with immune complexes. Most of
the differences between these three stimuli were quantitative
rather than qualitative. For example, changes in genes for
lysosome components and genes related to apoptosis were seen
with all stimuli but were greater in magnitude in TG neutrophils.
However, certain pathways were more specific to particular
stimuli. Genes related to the non-canonical NFkB pathway and to
the synthesis and use of glutathione were up-regulated in TG
neutrophils. Genes related to antigen processing and presentation,
uptake of modified lipoproteins, and the Nr4a family of
transcription factors were up-regulated in SF neutrophils. Recep-
tors for leukotrienes were up-regulated in UA neutrophils.
Finally, a regulatory model derived from ImmGen was used to
infer the involvement of many transcription factors and other
regulatory genes in up- and/or down-regulation of genes during
neutrophil activation. For example, Irf7 and Irf9 were implicated
in up-regulating a group of genes with increased expression in TG
or UA but not SF neutrophils. Irf5 was implicated in both up- and
down-regulation of many genes after all stimuli, and a novel role
for Irf5 in optimal induction of secretion of cytokines and
chemokines by a TLR9 agonist in neutrophils was confirmed
using Irf52/2 mice.
Three technical points must be discussed in considering the
validity of our data and their interpretation. First, since monocytes
contain 10–20 times as much mRNA per cell as do neutrophils, 1–
2% contamination could yield RNA that is 10–30% of monocyte
origin, so the possibility of monocyte/macrophage contamination
must be addressed in any study of gene expression in neutrophils
[13]. The finding that many genes were not expressed in
neutrophils but were expressed in all other leukocyte populations
argues against such contamination. In addition, a plot of gene
expression in macrophages versus TG-activated neutrophils
showed a poor correlation, leading to the conclusion that only 5
genes that were expressed at extremely high levels in macrophages
might give strong enough signals via contamination to produce
modestly elevated levels in TG neutrophils (data not shown).
Second, it is possible that some changes in gene expression among
neutrophils isolated from local sites actually derive from circulating
mediators rather than being elicited at the site of inflammation.
Arguing against this interpretation, the gene expression pattern in
bone-marrow neutrophils from arthritic mice was very similar to
expression in bone-marrow neutrophils from normal mice (data
not shown, and see Fig. 1B). Third, we are unable to address the
possibility that some of the differences seen comparing SF to TG
or UA neutrophils resulted from the time course (7 days versus 18
hours) rather than the stimuli, since there is no common time point
feasible for collection of neutrophils in all of these models.
The strengths of this study include the use of rigorous,
standardized protocols for collection of cells and data, both for
neutrophils and other leukocytes; the resulting ability to compare
neutrophils to numerous other leukocyte populations; and the
comparison of neutrophils activated in different ways in vivo. We
endeavored to begin analyses in an unbiased manner free of
hypotheses and to report all results regardless of novelty, so as to
establish a broad framework upon which we and others could use
this data-set as a resource for future hypothesis-driven experi-
ments.
The obvious limitation of this study is that most observations
were not confirmed at the level of protein expression or proof of
functional significance, the one exception being the demonstration
of the importance of neutrophil expression of Irf5 in optimal
secretion of multiple cytokines and chemokines. In addition, our
study would have been stronger if we had been able to include a
model of active bacterial infection. Since we must defend this study
in part as a hypothesis-generating exercise, it may be most
appropriate to end the discussion with some hypotheses:
N Some of the few genes that are highly specific to neutrophils,
such as Stfa2l1 and Mrgpr2a and b, will be found to be
essential for functions unique to neutrophils, such as NETosis
or other anti-microbial functions yet to be discovered.
N Proper regulation of anti-oxidant pathways and cellular
energetics, in part regulated by Nr4a family members, will
be found to be necessary for a neutrophil function essential to
the orderly development and resolution of acute inflammation,
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by the right mechanism(s).
N IRF family members will be important for induction of anti-
microbial and inflammatory mediators in neutrophils via
innate immune receptors.
N The limited capacity for translation in the mature neutrophil
will reveal a weak correlation between the amount of mRNA
and the amount of new protein produced, leading to new
insights into regulation of translation.
Supporting Information
Figure S1 Changes in gene expression in neutrophils activated
in vivo by different stimuli: synovial fluid (SF), thioglycollate (TG),
or uric acid (UA). A. Comparison of fold-changes in gene
expression relative to circulating neutrophils, among all 1283
genes showing significant variation across all conditions by
ANOVA. Non-transformed data are shown on a log scale. Log-
transformed data on a linear scale were used to calculate
correlation coefficients (r) and slopes. The slope in the middle
panel (1.08; 95% confidence interval 1.04–1.13) indicates higher
expression in TG than UA. B. Venn diagrams showing the
numbers of genes up- or down-regulated in the three activating
conditions. Top: fold-change .2 was used as the cut-off for all
conditions. Bottom: conditions were relaxed so that if one
condition had fold change .2, the others could have fold change
.1.5.
(EPS)
Table S1 Validation of neutrophil-specific gene expression by
RNA-Seq of major leukocyte populations.
(DOCX)
Table S2 Genes with increased expression relatively specific to a
stimulating condition.
(DOCX)
Text S1 Comparison of neutrophils activated by different
stimuli.
(DOCX)
File S1 Expression, in purified leukocyte populations in the
ImmGen database, of genes comprising a neutrophil signature in
the BioGPS database [47]. All genes in the BioGPS signature for
which there were comparable data in ImmGen are shown. Blue
indicates relatively low expression, red indicates high expression;
expression data were log-transformed and mean-centered for each
gene (i.e., row-normalized) using the HeatMapImage module of
GenePattern. Gene names are shown on the right, hierarchical
clustering of the expression patterns on the left, and ImmGen
populations (not clustered) along the top; text can be viewed using
a photo viewer with a magnification function. Neutrophil-related
populations at the left edge include common myeloid precursor
(SC_CMP_BM),granulocyte-monocyteprecursor(SC_GMP_BM),
bone-marrow neutrophils (GN_BM), blood neutrophils (GN_Bl),
neutrophils from inflamed synovial fluid (GN_Arth_SynF), uric-
acid-induced peritoneal neutrophils (GN_UrAc_PC), and thiogly-
collate-induced peritoneal neutrophils (GN_Thio_PC).
(PNG)
File S2 Gene expression in mouse neutrophils. Expression of all
1283 probes that passed filters for analysis (see Methods) is shown,
both in individual samples and as means of 3–4 replicate samples.
Assignment to clusters based on similar patterns of expression
across 4 conditions is shown in the final 2 columns: i) using our
original notation, in order to show where clusters produced by
ExpressCluster were pooled after inspection, and ii) using notation
used in Figure 3A, which provides the numbers of probes in each
cluster.
(XLSX)
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